Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

American Journal of Medicine

Volumn 113, Issue 2, 2002, Pages 91-98

  Cohen, Mardge H ^a,i   French, Audrey L ^a,b   Benning, Lorie ^c   Kovacs, Andrea ^d   Anastos, Kathryn ^e   Young, Mary ^f   Minkoff, Howard ^g   Hessol, Nancy A ^h  

^a Jr Hospital of Cook County   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g MAIMONIDES MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ The CORE Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

ACCIDENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ALGORITHM; ARTICLE; BRAIN DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; DEATH CERTIFICATE; DEPRESSION; DRUG OVERDOSE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEPATITIS C; HOMICIDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER FAILURE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; METABOLIC ACIDOSIS; MORTALITY; MULTIPLE CANCER; NEUROLOGIC DISEASE; PNEUMONIA; POISSON DISTRIBUTION; PRIORITY JOURNAL; SUICIDE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; POISSON DISTRIBUTION; PROBABILITY; RISK FACTORS; SAMPLING STUDIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0037159554     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01169-5     Document Type: Article

References (39)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group
3. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults and injection drug users, from 1995-1997
4. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival
5. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus
6. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
7. The relationship of clinic experience with advanced HIV and survival of women with AIDS
8. Race, sex, drug use, and progression of human immunodeficiency virus disease
9. A prospective study of HIV disease progression in female and male drug users
10. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS
11. Overall and cause-specific mortality in a cohort of homo/bisexual men, injecting drug users, and female partners of HIV-infected men. Pulmonary Complications of Human Immunodeficiency Virus Infection Study Group
12. The Women's Interagency HIV Study
13. Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women
14. Changing patterns of mortality across Europe in patients infected with HIV-1
15. Natural history of HIV infection in the era of combination antiretroviral therapy
16. Impact of COMBINATION ART on causes of death of persons with late-stage AIDS
17. Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999
18. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study
19. Mortality among drug users in the AIDS era
20. Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996
21. Association of cancer with AIDS-related immunosuppression in adults
22. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women
23. Clinical applications. Women and HIV: Creating an ambience of caring
24. Mortality among childbearing-age women in Campinas, Sao Paulo (1985-1994)
25. Domestic violence and childhood sexual abuse in women with HIV infection and women at risk for HIV
26. Violence among women with or at risk for HIV infection
27. Accuracy of mortality data for interstitial lung diseases in New Mexico, USA
28. Tuberculosis surveillance using death certificate data, New York City, 1992
29. Death certificates. The need for further guidance
30. Accuracy of death certificate completion: The need for formalized physician training
31. "Inaccuracy" in death certification - Where are we now?
32. Race/ethnicity misclassification of persons reported with AIDS. The AIDS Mortality Project Group and The Supplement to HIV/AIDS Surveillance Project Group
33. Trends in mortality statistics in England and Wales with particular reference to AIDS from 1984 to April 1987
34. Causes of death among persons reported with AIDS
35. The reporting of HIV/AIDS deaths in women
36. Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates
37. Completeness of AIDS reporting and quality of AIDS death certification in Tuscany (Italy): A linkage study between surveillance system of cases and death certificates